Trademark: 88534482
Word
CANCEROME
Status
Pending
Status Code
807
Status Date
Friday, September 8, 2023
Serial Number
88534482
Mark Type
4000
Filing Date
Wednesday, July 24, 2019
Published for Opposition
Tuesday, June 16, 2020

Trademark Owner History
INanoBio Inc - Owner At Publication

Classifications
5 Diagnostic agents, preparations and substances for medical purposes; Diagnostic biomarker reagents for medical purposes; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancer; Diagnostic media for bacteriological cultures; Diagnostic preparations for medical and veterinary use; Diagnostic preparations for medical or veterinary purposes; Diagnostic preparations for medical purposes; Diagnostic preparations for veterinary purposes; Diagnostic radiopharmaceutical agent for use in PET imaging; Diagnostic radiopharmaceutical preparations; Diagnostic reagents and contrast media for medical use; Diagnostic reagents for medicinal use; Diagnostic test patch for application to the skin for determining allergic reactions; Diagnostic test patch for application to the skin for determining allergies; Therapeutic vaccines; Anti-cancer preparations; Biological preparations for the treatment of cancer; Biometallic compounds for consumption and/or injection for use in medical imaging and for diagnostic purposes; Contrasting agent for ultrasound diagnostic imaging; Medical diagnostic reagents; Medical diagnostic reagents and assays for testing body fluids for microorganisms; Medical diagnostic reagents and assays for testing of body fluids; Medical diagnostic reagents for the analysis of body fluids; Medical diagnostic test strips for use in the field of early detection of cancer; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Radio-isotope markers for therapeutic or diagnostic use; Radioactive pharmaceutical preparations for use in vivo diagnostic or therapeutic use; Radiopharmaceutical imaging and detection agents for diagnosing and monitoring cancer; Veterinary diagnostic reagents
1 Diagnostic preparations for clinical or medical laboratory use; Diagnostic preparations for scientific or research use; Diagnostic preparations for scientific or research use other than for medical use; Diagnostic preparations for scientific use; Diagnostic preparations other than for medical or veterinary purposes; Diagnostic preparations used in science; Diagnostic preparations, other than for medical or veterinary purposes; Diagnostic reagents and preparations, except for medical or veterinary use; Diagnostic reagents for clinical or medical laboratory use; Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; Diagnostic reagents for scientific or research use; Diagnostic reagents for scientific use; Active chemical ingredients for use in the manufacture of anti-cancer drugs; Immunohistochemistry detection kits consisting of mouse secondary reagents, DAB chromogens, DAB buffers, peroxidase blocking reagent, and hematoxylin, for anatomic pathology purposes in the medical diagnostics industry; Laboratory chemicals, namely, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use
44 Medical diagnostic services for cancer detection
10 Diagnostic apparatus for the detection of cancer; Diagnostic apparatus for the detection of periodontal disease; Diagnostic kits consisting primarily of probes, buffers and reagents for use in microbial testing; Diagnostic penlights for medical purposes; Audio oscillators for detecting toxins and pathogens in the body for medical diagnostic purposes; Cytometers for medical diagnostic use; Dynamometers for diagnostic muscle strength testing; Electromagnetic medical diagnostic imaging apparatus; Flow cytometers for medical diagnostic uses; Hematology analyzers for medical diagnostic uses; Medical diagnostic apparatus for analyzing and measuring electrolytes in the body; Medical diagnostic apparatus for detecting cancer; Medical diagnostic apparatus for testing DNA and RNA samples; Medical diagnostic instruments for the analysis of body fluids; Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; Medical apparatus and instruments for diagnostic radiopharmaceutical use; Medical apparatus for detecting cancer; Medical device for detecting cancer; Medical device for treating cancer; Nuclear medicine diagnostic imaging apparatus; Organoleptic diagnostic testing apparatus for medical, dental or cosmetic use; Orthopedic devices for diagnostic and therapeutic use; Radiological apparatus for diagnostic and medical purposes, namely, magnetic resonance imager; Sample preparation device for medical diagnostic uses; Ultrasonic medical diagnostic apparatus; Ultrasound diagnostic apparatus; X-ray diagnostic apparatus
42 Diagnostic services in the field of machines that detect cancer; Automobile transmission diagnostic services; Computer diagnostic services; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Medical and scientific research in the field of cancer treatment and diagnosis; Medical research services in the field of cancer; Providing a website featuring information about investigational medical devices, diagnostics and drugs; Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing medical testing services and information in the field of cancer research and disease classification; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Scientific research for medical purposes in the area of cancerous diseases
CANCER OME

Trademark Events
Dec 7, 2023
Application Extension Granted/Receipt Provided
Dec 7, 2023
Application Extension To Response Period - Received
Sep 8, 2023
Notification Of Non-Final Action E-Mailed
Sep 8, 2023
Non-Final Action E-Mailed
Sep 8, 2023
Su - Non-Final Action - Written
Aug 14, 2023
Statement Of Use Processing Complete
Aug 11, 2023
Use Amendment Filed
Aug 11, 2023
Teas Statement Of Use Received
Jan 24, 2023
Notice Of Approval Of Extension Request E-Mailed
Jan 23, 2023
Sou Extension 5 Granted
Jan 11, 2023
Sou Extension 5 Filed
Jan 11, 2023
Sou Teas Extension Received
Aug 13, 2022
Notice Of Approval Of Extension Request E-Mailed
Aug 11, 2022
Sou Extension 4 Granted
Aug 11, 2022
Sou Extension 4 Filed
Aug 11, 2022
Sou Teas Extension Received
Jan 6, 2022
Notice Of Approval Of Extension Request E-Mailed
Jan 4, 2022
Sou Extension 3 Granted
Jan 4, 2022
Sou Extension 3 Filed
Jan 4, 2022
Sou Teas Extension Received
Sep 25, 2021
Notice Of Approval Of Extension Request E-Mailed
Sep 24, 2021
Sou Extension 2 Granted
Aug 11, 2021
Sou Extension 2 Filed
Sep 23, 2021
Case Assigned To Intent To Use Paralegal
Sep 15, 2021
Notice Of Revival - E-Mailed
Sep 15, 2021
Sou Extension Received With Teas Petition
Sep 15, 2021
Petition To Revive-Granted
Sep 15, 2021
Teas Petition To Revive Received
Sep 13, 2021
Abandonment Notice E-Mailed - No Use Statement Filed
Sep 13, 2021
Abandonment - No Use Statement Filed
Feb 18, 2021
Teas Change Of Correspondence Received
Feb 18, 2021
Teas Withdrawal Of Attorney Received-Firm Retains
Feb 18, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Feb 18, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Feb 4, 2021
Notice Of Approval Of Extension Request E-Mailed
Feb 2, 2021
Sou Extension 1 Granted
Feb 2, 2021
Sou Extension 1 Filed
Feb 2, 2021
Sou Teas Extension Received
Aug 11, 2020
Noa E-Mailed - Sou Required From Applicant
Jun 16, 2020
Official Gazette Publication Confirmation E-Mailed
Jun 16, 2020
Published For Opposition
May 27, 2020
Notification Of Notice Of Publication E-Mailed
May 14, 2020
Approved For Pub - Principal Register
May 11, 2020
Teas/Email Correspondence Entered
May 10, 2020
Correspondence Received In Law Office
May 10, 2020
Teas Response To Office Action Received
Nov 22, 2019
Notification Of Non-Final Action E-Mailed
Nov 22, 2019
Non-Final Action E-Mailed
Nov 22, 2019
Non-Final Action Written
Nov 20, 2019
Previous Allowance Count Withdrawn
Nov 12, 2019
Withdrawn From Pub - Og Review Query
Oct 30, 2019
Assigned To Lie
Oct 21, 2019
Approved For Pub - Principal Register
Oct 21, 2019
Examiner's Amendment Entered
Oct 21, 2019
Notification Of Examiners Amendment E-Mailed
Oct 21, 2019
Examiners Amendment E-Mailed
Oct 21, 2019
Examiners Amendment -Written
Oct 14, 2019
Assigned To Examiner
Aug 2, 2019
New Application Office Supplied Data Entered
Jul 29, 2019
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24